These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

66 related items for PubMed ID: 761221

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Dihydrofolate reductase activity in primary brain tumors in children.
    Tzortzatou-Stathopoulou F, Panagiotou JP, Xaidara A, Karydis K, Sfakianos G, Evagellinos B.
    Am J Pediatr Hematol Oncol; 1993 Aug; 15(3):316-9. PubMed ID: 8328645
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Dihydrofolate reductase from Kaposi's sarcoma-associated herpesvirus.
    Cinquina CC, Grogan E, Sun R, Lin SF, Beardsley GP, Miller G.
    Virology; 2000 Mar 01; 268(1):201-17. PubMed ID: 10683342
    [Abstract] [Full Text] [Related]

  • 5. Selective expression of methotrexate-resistant dihydrofolate reductase (DHFR) activity in mice transduced with DHFR retrovirus and administered methotrexate.
    Vinh DB, McIvor RS.
    J Pharmacol Exp Ther; 1993 Nov 01; 267(2):989-96. PubMed ID: 8246174
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Flow cytometric analysis of mammalian glial cultures treated with methotrexate.
    Serrano EE, Schimke RT.
    Glia; 1990 Nov 01; 3(6):539-49. PubMed ID: 2148556
    [Abstract] [Full Text] [Related]

  • 8. [Schmidt Ruppin-D-ASV-induced primary rat brain tumor model for therapeutic screening].
    Nakamura O, Hojo S, Takakura K, Nagashima K, Ishizaki R.
    No To Shinkei; 1982 Jul 01; 34(7):691-7. PubMed ID: 6291561
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Elevation of dihydrofolate reductase, thymidylate synthetase, and thymidine kinase in cultured mammalian cells after exposure to folate antagonists.
    Chello PL, McQueen CA, DeAngelis LM, Bertino JR.
    Cancer Res; 1976 Jul 01; 36(7 PT 1):2442-9. PubMed ID: 1277151
    [Abstract] [Full Text] [Related]

  • 12. Design and synthesis of dihydrofolate reductase inhibitors encompassing a bridging ester group. Evaluation in a mouse colitis model.
    Graffner-Nordberg M, Fyfe M, Brattsand R, Mellgård B, Hallberg A.
    J Med Chem; 2003 Jul 31; 46(16):3455-62. PubMed ID: 12877583
    [Abstract] [Full Text] [Related]

  • 13. Characterization and comparative studies of zebrafish and human recombinant dihydrofolate reductases--inhibition by folic acid and polyphenols.
    Kao TT, Wang KC, Chang WN, Lin CY, Chen BH, Wu HL, Shi GY, Tsai JN, Fu TF.
    Drug Metab Dispos; 2008 Mar 31; 36(3):508-16. PubMed ID: 18056255
    [Abstract] [Full Text] [Related]

  • 14. [Histopathological and autoradiographical studies of experimental brain tumors after continuous local chemotherapy--acute stage in rat models].
    Shimura T, Teramoto A, Aihara K.
    Gan To Kagaku Ryoho; 1997 Apr 31; 24(6):713-8. PubMed ID: 9126309
    [Abstract] [Full Text] [Related]

  • 15. Effect of malnutrition on methotrexate toxicity and tissue levels of dihydrofolate reductase in the rat.
    Grossie VB, Ho DH, Loo TL.
    Cancer Treat Rep; 1982 Jan 31; 66(1):85-9. PubMed ID: 7053272
    [Abstract] [Full Text] [Related]

  • 16. Microglia cyclooxygenase-2 activity in experimental gliomas: possible role in cerebral edema formation.
    Badie B, Schartner JM, Hagar AR, Prabakaran S, Peebles TR, Bartley B, Lapsiwala S, Resnick DK, Vorpahl J.
    Clin Cancer Res; 2003 Feb 31; 9(2):872-7. PubMed ID: 12576462
    [Abstract] [Full Text] [Related]

  • 17. A comparison of dihydrofolate reductase activity in intact leukemia cells and squamous cell carcinoma.
    FitzGerald GB, Wick MM.
    Anticancer Drug Des; 1989 Jun 31; 4(1):79-87. PubMed ID: 2757754
    [Abstract] [Full Text] [Related]

  • 18. Regulation of dihydrofolate reductase in human breast cancer cells and in mutant hamster cells transfected with a human dihydrofolate reductase minigene.
    Cowan KH, Goldsmith ME, Ricciardone MD, Levine R, Rubalcaba E, Jolivet J.
    Mol Pharmacol; 1986 Jul 31; 30(1):69-76. PubMed ID: 3724746
    [Abstract] [Full Text] [Related]

  • 19. Telomerase activity in microdissected human gliomas.
    Weil RJ, Wu YY, Vortmeyer AO, Moon YW, Delgado RM, Fuller BG, Lonser RR, Remaley AT, Zhuang Z.
    Mod Pathol; 1999 Jan 31; 12(1):41-6. PubMed ID: 9950161
    [Abstract] [Full Text] [Related]

  • 20. Evidence that Cereport's ability to increase permeability of rat gliomas is dependent upon extent of tumor growth: implications for treating newly emerging tumor colonies.
    Bartus RT, Snodgrass P, Dean RL, Kordower JH, Emerich DF.
    Exp Neurol; 2000 Jan 31; 161(1):234-44. PubMed ID: 10683290
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.